Dr. Inglesby is the Director of the Center for Health Security of the Johns Hopkins Bloomberg School of Public Health. The Center for Health Security is dedicated to protecting people's health from the consequences of epidemics and disasters. Dr. Inglesby is also Professor in the Department of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health with a Joint Appointment in the Johns Hopkins School of Medicine.
Dr. Inglesby's work is internationally recognized in the fields of public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats. He is Chair of the Board of Scientific Counselors, Office of Public Health Preparedness and Response, US Centers for Disease Control and Prevention (CDC). He is also Chair of the National Advisory Council of the Robert Wood Johnson Foundation’s National Health Security Preparedness Index. He was a member of the CDC Director’s External Laboratory Safety Workgroup that examined biosafety practices of the CDC, the National Institutes of Health (NIH), and the Food and Drug Administration (FDA) following high-profile laboratory incidents in federal agencies. He was on the 2016 Working Group assessing US biosecurity on behalf of the President’s Council of Advisors on Science and Technology (PCAST). He has served on committees of the Defense Science Board, the National Academies of Sciences, the Institute of Medicine, and in an advisory capacity to NIH, BARDA, DHS, and DARPA.
Dr. Inglesby has authored or co-authored more than 115 publications, including peer-reviewed research, reports, and commentaries on issues related to health security and preparedness for epidemics, biological threats, and disasters. He is Editor-in-Chief of the peer-reviewed journal Health Security, which he helped establish in 2003. He was a principal editor of the JAMA book Bioterrorism: Guidelines for Medical and Public Health Management. He has been invited to brief White House officials from the past 4 presidential administrations on national biosecurity challenges and priorities, and he has delivered Congressional testimony on a number of issues related to public health preparedness and biosecurity. He is regularly consulted by major news outlets for his expertise. He is a member of the Board of Directors of PurThread, a company dedicated to developing antimicrobial textiles.
Dr. Inglesby completed his internal medicine and infectious diseases training at Johns Hopkins University School of Medicine, where he also served as Assistant Chief of Service in 1996-97. Dr. Inglesby received his MD from Columbia University College of Physicians and Surgeons and his BA from Georgetown University. He sees patients in a weekly infectious disease clinic.